Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Takara Bio Inc.
DescriptionMutant of herpes simplex virus type 1 (HSV-1)
Molecular Target Not applicable
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationHead and neck cancer
Indication DetailsTreat head and neck cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today